the role of thromboinflammation in chronic mpns
Published 1 year ago • 160 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
0:52
is there a role for combination therapy in cml?
-
1:39
the mechanism of action of navtemadlin and its role in mf
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
1:54
therapeutic approaches in the front-line for patients with ptcl
-
3:37
an overview of platelet dysfunction in patients with myeloproliferative neoplasms
-
1:30
the use of pirtobrutinib in richter's transformation: data from the bruin trial
-
1:06:04
itp: novel treatments
-
9:04
how are et, pv and myelofibrosis monitored?
-
5:21
what is prothrombin time?
-
2:16
the role of covalent btkis in the management of cll
-
1:34
are thrombotic risk and progression in et predictable?
-
0:52
rilzabrutinib: a novel promising btk inhibitor being explored in itp
-
2:13
current and emerging treatment options for patients with mf who are ineligible for ruxolitinib
-
2:10
phase i study of ruxolitinib in combination with abemaciclib in patients with myelofibrosis
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
1:32
genomic evolution & resistance to pirtobrutinib in covalent btk inhibitor pre-treated cll
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
1:53
novel laboratory-based therapeutic approach in al amyloidosis: investigating flc secretion
-
2:12
results from a phase i trial of tinostamustine in patients with r/r classical hl
-
1:18
novel approaches for the treatment of myelofibrosis: navitoclax ruxolitinib
-
3:49
the impact of allosct versus blood transfusion & iron chelation on the qol of patients with tdt